(Q46415268)

English

Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy.

scientific article published on 6 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

based on heuristic

inferred from title

author name string

Gil Chernin

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Amir Gal-Oz

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Eyal Ben-Assa

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Idit F Schwartz

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Talia Weinstein

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Doron Schwartz

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Donald S Silverberg

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

6 November 2011

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Clinical Cardiology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

35

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

32-36

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Eplerenone in patients with systolic heart failure and mild symptoms

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Hyperkalemia: a threat to RAAS inhibition?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Safety of spironolactone use in ambulatory heart failure patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Damned if you do, damned if you don't: potassium binding resins in hyperkalemia.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Ileocolic perforation secondary to sodium polystyrene sulfonate in sorbitol use: a case report

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Colonic necrosis due to sodium polystyrene sulfate (Kayexalate).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Colonic necrosis due to oral kayexalate in a critically-ill patient

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Left ventricular ejection fraction: are the revised cut-off points for defining systolic dysfunction sufficiently evidence based?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

Hypernatraemia induced by sodium polystyrene sulphonate (Kayexalate) in two extremely low birth weight newborns

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

To bind or not to bind: potassium-lowering drugs in heart failure.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.20987

21 January 2018

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

https://pubmed.ncbi.nlm.nih.gov/22057933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypokalaemia and hypomagnesaemia in an oedematous diabetic patient with advanced renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22057933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia--changes in serum potassium levels with or without a RAAS inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22057933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22057933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic Acidosis Reversed by the Combination of Magnesium Hydroxide and a Cation-Exchange Resin

1 reference

https://pubmed.ncbi.nlm.nih.gov/22057933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22057933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CLC.20987

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22057933%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46415268&oldid=1411240658"